About: Developing Covid-19 Vaccines at Pandemic Speed

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Developing Covid-19 Vaccines at Pandemic Speed Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 30 March 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en marzu de 2020 (ast) scientific article published on 30 March 2020 (en) наукова стаття, опублікована 30 березня 2020 (uk)
publication date	wds:Q90754562-CB6C8C05-666E-43F8-9688-9F8FFF754B72
publication date	2020-03-30 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q90754562-B8CA6D13-E91F-47DF-AADD-140BA02B973B
language of work or name	English
author name string	wds:Q90754562-3EE8EFAE-2779-4920-8F56-AF813D2B26DE wds:Q90754562-96444662-F65E-42A2-824F-F613E8518EC8 wds:Q90754562-C5B81A68-5EFD-449A-9C48-7CD8753C24E0 wds:Q90754562-E72C9493-0B97-494F-ACA2-E135D2C3E823
author name string	Melanie Saville Richard Hatchett Nicole Lurie Jane Halton
rdfs:label	Developing Covid-19 Vaccines at Pandemic Speed (en) Developing Covid-19 Vaccines at Pandemic Speed (nl)
skos:prefLabel	Developing Covid-19 Vaccines at Pandemic Speed (en) Developing Covid-19 Vaccines at Pandemic Speed (nl)
name	Developing Covid-19 Vaccines at Pandemic Speed (en) Developing Covid-19 Vaccines at Pandemic Speed (nl)
title	wds:Q90754562-2CBC3733-7781-4F82-9BEE-A53BA33ADC98
title	Developing Covid-19 Vaccines at Pandemic Speed (en)
instance of	wds:Q90754562-F9A521E3-B2D0-4293-8DD1-41FE2683B858
instance of	scholarly article
main subject	wds:Q90754562-3C512B4D-6F2F-472C-876D-2D4B87B9EA53 wds:Q90754562-3F4AB2AC-FA88-4DCD-B4EB-638AEE52C8B3 wds:Q90754562-CC705DFF-2433-4EC7-B456-9BCE0FBC4B61 wds:Q90754562-D5250F69-3994-4E52-A8F2-A4DA9B04808E wds:Q90754562-e0866882-4fed-1628-f6ff-9a5fcb0b39cf
main subject	SARS-CoV-2 COVID-19 pandemic pandemic COVID-19 mortality COVID-19 vaccine
PubMed ID	wds:Q90754562-7087AA68-813C-40F0-A447-FDC296E676F9
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32227757
PubMed ID	32227757
published in	wds:Q90754562-58C8F890-9AFA-48CC-BAE3-E962284FBE4A
published in	The New England Journal of Medicine
DOI	wds:Q90754562-D641508D-CBA6-4B83-95A8-E4628CB0C147
DOI	http://dx.doi.org/10.1056/NEJMP2005630
DOI	10.1056/NEJMP2005630
Dimensions Publication ID	wds:Q90754562-C98B120B-D599-4500-A7DC-23D0D174D3F6
Dimensions Publication ID	1125996221
COVIDWHO ID	wds:Q90754562-A827747A-FFB1-4AB4-BB37-F20D237467FE
COVIDWHO ID	covidwho-20781
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q90754562
is cites work of	COVID - 19 post Hematopoietic Cell Transplant, a Report of 11 Cases from a Single Center COVID-19 human challenge studies: ethical issues Coronavirus Human Infection Challenge Studies: Assessing Potential Benefits and Risks The trinity of COVID-19: immunity, inflammation and intervention Immunological considerations for COVID-19 vaccine strategies Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial Managing Patients with Multiple Myeloma during the COVID-19 Pandemic: Recommendations from an Expert Panel - ABHH Monoclonal Gammopathies Committe A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques Rapid development of an inactivated vaccine candidate for SARS-CoV-2 The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA The starting line for COVID-19 vaccine development Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer Confronting hidden COVID-19 burden: a telemedical solution for elective urological outpatient clinics Disease and healthcare burden of COVID-19 in the United States The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19 COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives Health risks and outcomes that disproportionately affect women during the Covid-19 pandemic: A review A systematic review of SARS-CoV-2 vaccine candidates Vaccines for COVID-19: The current state of play Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19 Advancing COVID-19 vaccines - avoiding different regulatory standards for different vaccines and need for open and transparent data sharing A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV2? RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response Antibody testing will enhance the power and accuracy of COVID-19-prevention trials Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity The intriguing features of COVID-19 in children and its impact on the pandemic Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies Potential Fast COVID-19 Containment With Trehalose Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey Nanoceria as a possible agent for the management of COVID-19 Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group How did we get here? A short history of COVID-19 and other coronavirus-related epidemics Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients COVID-19: Second Wave or Multiple Peaks, Natural Herd Immunity or Vaccine-We Should be Prepared Human immunology and immunotherapy: main achievements and challenges Improving Non-specific Immunity to Coronavirus Disease (COVID-19) by the Novelty, Diversity, and Quantity of Antigen The day after COVID-19 in IBD: how to go back to 'normal'

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software